Surgery during COVID 19

From Eric Liu, MD, FACS, Surgeon, Rocky Mountain Cancer Centers Midtown, Denver, CO

The medical field is in terrible flux right now and nothing is definitive. All we can give are general guidelines for how to decide on surgery. READ MORE...


Lutathera (PRRT) during COVID 19

From Erik Mittra, MD, PhD, Nuclear Medicine, Oregon Health & Sciences University

Questions are answered about whether Lutathera (PRRT) treatment creates an increased risk of COVID 19 and what to be aware of if you are currently taking or considering the treatment. READ MORE...


LungNETs and COVID 19

From Robert Ramirez, DO, FACP, Oncologist, Ochsner Medical Center

Questions are answered about whether there is an increased risk of COVID 19 infection among LungNETs and if positive could symptoms be more severe? READ MORE...


Systemic (SSA, Chemo, etc.) Treatment and COVID 19

From Daniel Halperin, MD, Oncologist, University of Texas MD Anderson Center

The risks and benefits of medical interaction have fundamentally changed for our patients right now. With each interaction there is an increased risk to our patients of COVID 19 infection, and there is also an increased risk of spreading the virus to other people, who in this case are also likely to be vulnerable and/or older cancer patients. READ MORE...

Our SSA and Diarrhea Control Resources page


COVID 19 & NETS Q&A

From NorCalCarciNET

Q & A courtesy of Dr. Pamela Kunz, MD (Oncology) and Dr. Janice (Wes) Brown, MD (Infectious Disease) of Stanford University. norcalcarcinet.org


2020 Communication with HCP's

From Eric Liu, MD, FACS, Surgeon, Rocky Mountain Cancer Centers Midtown, Denver, CO

TELEMEDICINE is a new tool for patients and physicians to communicate outside of traditional office visits. Eric Liu, MD explains how the technology is currently working in his practice during COVID 19 concerns. READ MORE...